Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement and Release Date of Third Quarter 2007 Financi...(ll free at1-800-662-5200. The Company...)

The Company also announced that it will report its third quarter 2007 financial results on Thursday, November 8, 2007, after the market close. The Company expects that voting results from the special meeting also will be reported on that date. The Company will host a live webcast at 4:30 p.m. EST that day to discuss these results.

The live webcast can be accessed at:

http://phx.corporate-ir.net/phoenix.zhtml?p=irol-

eventDetails&c=100445&eventID=1673091 (Please copy and paste into your browser) or via the Nabi Biopharmaceuticals website at http://www.nabi.com.

If you do not have Internet access, the U.S./Canada call-in number is 866-202-4683 and the international call-in number is 617-213-8846. The participant passcode is 65486127. An audio replay will be available for U.S./Canada callers at 888-286-8010 and for international callers at 617-801- 6888. The replay passcode is 91953104. An archived version of the webcast will also be available on the Company's website, http://www.nabi.com. Both the audio replay and the archived webcast will be available through November 15, 2007. The press release will be available on the company's website at http://www.nabi.com.

About Nabi Biopharmaceuticals

Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and, in certain areas, market products that target serious medical conditions in the areas of hepatitis and transplants, gram positive bacterial infections and nicotine addiction. We are a vertically integrated company with sales of antibodies and other biologics, including Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], a pipeline of products in various stages of development and a state-of-t
'/>"/>